/
© 2026 RiffOn. All rights reserved.

Get your free personalized podcast brief

We scan new podcasts and send you the top 5 insights daily.

  1. AI For Pharma Growth
  2. E217: The Diagnostic Room: Pilot purgatory: why pharma AI stalls after the first wins
E217: The Diagnostic Room: Pilot purgatory: why pharma AI stalls after the first wins

E217: The Diagnostic Room: Pilot purgatory: why pharma AI stalls after the first wins

AI For Pharma Growth · May 12, 2026

Pharma's AI problem isn't experimentation, but execution. Many projects get stuck in 'pilot purgatory,' failing to scale and show ROI.

More AI Pilots Worsen Pharma's Core Problem of Scaling and ROI Justification

Pharma's primary AI challenge is not a lack of experimentation but a failure to execute, scale, and justify ROI. Launching additional pilots only accelerates the activity that keeps companies stuck, compounding the problem instead of solving it.

E217: The Diagnostic Room: Pilot purgatory: why pharma AI stalls after the first wins thumbnail

E217: The Diagnostic Room: Pilot purgatory: why pharma AI stalls after the first wins

AI For Pharma Growth·2 days ago

AI Adoption Failures Signal Organizational Design Flaws, Not Employee Resistance

When AI tools are not adopted, leadership often blames resistance and prescribes more training. The real issue is typically a structural failure, such as not involving local teams in the model's design or misaligned incentives between insight generators and decision-makers.

E217: The Diagnostic Room: Pilot purgatory: why pharma AI stalls after the first wins thumbnail

E217: The Diagnostic Room: Pilot purgatory: why pharma AI stalls after the first wins

AI For Pharma Growth·2 days ago

Governance Structures Enabling AI Experiments Often Become Bottlenecks Preventing Scale

The very governance bodies created to foster innovation, like AI councils, frequently stifle growth. As projects move from pilot to scale, these groups can become bottlenecks, multiplying reviews and killing momentum because they were designed for permission to start, not permission to grow.

E217: The Diagnostic Room: Pilot purgatory: why pharma AI stalls after the first wins thumbnail

E217: The Diagnostic Room: Pilot purgatory: why pharma AI stalls after the first wins

AI For Pharma Growth·2 days ago

Delaying AI Scaling Actively Degrades Organizational Capacity and Widens Competitive Gaps

Failure to scale AI is not a neutral problem. Each quarter in "pilot purgatory" harms the organization by increasing skepticism, sponsor fatigue, and political complexity, making future transformation harder. Meanwhile, competitors build a compounding decision advantage that becomes an organizational redesign challenge to catch.

E217: The Diagnostic Room: Pilot purgatory: why pharma AI stalls after the first wins thumbnail

E217: The Diagnostic Room: Pilot purgatory: why pharma AI stalls after the first wins

AI For Pharma Growth·2 days ago

Local Teams' "Resistance" to Central AI Is a Rational Response to Lacking Ownership

When local teams don't adopt a centrally-developed AI, it's not irrational resistance. It's a predictable response to executing a system they had no role in creating and cannot formally challenge, even when it contradicts their on-the-ground knowledge. Non-adoption becomes their only form of dissent.

E217: The Diagnostic Room: Pilot purgatory: why pharma AI stalls after the first wins thumbnail

E217: The Diagnostic Room: Pilot purgatory: why pharma AI stalls after the first wins

AI For Pharma Growth·2 days ago

Scaling AI Is a Leadership Responsibility, Not a Delegatable Delivery Task

Companies fail when they frame AI scaling as a technical challenge and delegate it to a digital team. Successful scaling depends on senior leadership making hard decisions about governance, ownership, and incentives—choices that cannot be made by lower-level teams. You can't tool your way out of a governance problem.

E217: The Diagnostic Room: Pilot purgatory: why pharma AI stalls after the first wins thumbnail

E217: The Diagnostic Room: Pilot purgatory: why pharma AI stalls after the first wins

AI For Pharma Growth·2 days ago

Stalled AI Projects Directly Cause Top AI Talent to Leave the Organization

Your most skilled AI professionals are also the most mobile. They recognize when their sophisticated work isn't creating value and will leave out of frustration. This turns a project-scaling issue into a critical talent retention problem, as your best people notice when intelligent work goes nowhere.

E217: The Diagnostic Room: Pilot purgatory: why pharma AI stalls after the first wins thumbnail

E217: The Diagnostic Room: Pilot purgatory: why pharma AI stalls after the first wins

AI For Pharma Growth·2 days ago